| 何文,邬冬芳,胡向东,张晓蓉,郭莉,梁晓宁,郑永才.超声引导经皮穿刺微波治疗恶性肿瘤的临床研究[J].中国医学影像技术,2006,22(12):1860~1865 |
| 超声引导经皮穿刺微波治疗恶性肿瘤的临床研究 |
| Clinical study on ultrasound-guided percutaneous microwave ablation for malignant tumor |
| 投稿时间：2006-07-28 修订日期：2006-10-12 |
| DOI： |
| 中文关键词: 微波 肝肿瘤 骨肿瘤 肺肿瘤 介入性超声 |
| 英文关键词:Microwave Liver neoplasms Bone neoplasms Lung neoplasms Interventional ultrasound |
| 基金项目: |
|
| 摘要点击次数: 1932 |
| 全文下载次数: 743 |
| 中文摘要: |
| 目的 探讨超声引导微波消融治疗恶性肿瘤的疗效和可行性。方法 373例实体瘤(肝癌、肺癌和骨肿瘤等)进行超声引导下经皮穿刺微波消融治疗。结果 所有病例治疗后全身情况好转,症状减轻或消失,患者饮食明显增加,生活质量、生存率提高,肿块缩小,肿瘤内血流消失或减少。27例超声引导下活检肿瘤完全坏死。≤5 cm肝癌治疗后有效率(CR+PR)83.2%,1,2,3,5年生存率分别是88.8%,68.5%,60.9%,38.6%,一次完全消融率60.9%。>5 cm肝癌有效率(CR+PR)61.9%, 1,2,3,5年生存率分别是67.8%,51.7%,39.8%,24.6%,一次完全消融率36.9%。微波联合TACE 治疗大肝癌1,2,3,5年生存率分别是 88.6%,71.4%,60.0%,42.9%;肺癌微波治疗有效率(CR+PR)64.7%,一次完全消融67%;骨肿瘤微波治疗有效率(CR+PR)100%,一次完全消融率64.7%,疼痛减轻或消失,肢体功能恢复。无其他严重并发症发生。结论 超声引导微波消融治疗肝、肺和骨肿瘤等实体瘤安全、可行、有效。 |
| 英文摘要: |
| Objective To evaluate the feasibility and efficiency of ultrasound-guided percutaneous microwave coagulation therapy for malignant tumor. Methods A total of 373 cases of solid carcinoma, which included 340 cases of hepatic cancer, 17 cases of lung cancer, 13 cases of bone tumor, 2 cases of kidney tumor and 1 case of adrenal tumor, were received ultrasound-guided percutaneous microwave ablation therapy. Results After the treatment, all lesions were decreased in size and blood flow in nodules disappeared. Repeated biopsy in 27 patients showed complete necroses of tumors. There was no enhancement in the tumor on enhanced CT scans. All patients were better than before, their symptoms were relief or disappearance, and the appetite were increase significantly. The effective rate (CR+PR) was 83.2%, and the 1, 2, 3, 5 years survival rates were 88.8%, 68.5%, 60.9% and 38.6% respectively in the small hepatic cancer (≤5 cm), whereas in the large hepatic cancer (>5 cm), the effective rate (CR+PR) was 61.9%, and the 1, 2, 3, 5 years survival rates were 67.8%, 51.7%, 39.8%, and 24.6%, respectively. The 1, 2, 3, 5 years survival rates in microwave ablation and transcatheter arterial embolization were 88.6%, 71.4%, 60.0% and 42.9% respectively. The effective rates (CR+PR) in patients with lung cancer and bone tumor were 64.7% and 100%. Patients felt the pain disappeared or remissive and the limbs functions were recovered in the bone tumor. There were no severe complications in the patients with malignant tumor by ultrasound-guided percutaneous microwave ablation therapy. Conclusion Ultrasound-guided percutaneous microwave ablation therapy is a safe, effective and feasible method for solid carcinoma, such as hepatic cancer, lung cancer, bone tumor. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
